Abstract |
Recently, as a new type of anti-AIDS drug, an HIV-1 protease inhibitor, KNI-174, has been synthesized; it shows a potent and selective HIV-1 protease inhibitory activity in vitro. In this study, we developed an HPLC assay system for KNI-174 in rat plasma and examined the pharmacokinetics of KNI-174 in rats using this assay method after both intravenous (i.v.) and intraduodenal (i.d.) administrations to obtain the disposition characteristics and bioavailability of this new anti-AIDS drug. This HPLC assay method is specific to KNI-174 and the standard curve was linear from 0.02 to 30 micrograms ml-1 plasma. After i.v. administration, 10.0 mg kg-1, KNI-174 disappeared from the rats' plasma in a three-exponential decay. The mean terminal elimination half-life, t1/2 lambda z, was 3.97 +/- 0.19 (S.E.) h, the total body clearance, CLtot, was 9.53 +/- 1.08 ml min-1 and the distribution volume at steady state, Vd,ss, was 7070 +/- 960 ml kg-1. In the case of the i.d. administration, 10.0 mg kg-1, the mean peak plasma concentration, Cmax, and the peak time, tmax, were 0.196 +/- 0.076 micrograms ml-1 and 0.444 +/- 0.193 h, respectively. The bioavailability of KNI-174 till infinity, BA(0-infinity), was 5.37 per cent. Because the IC50 of KNI-174 against HIV-1 in PHA-PBM was 138 ng ml-1, the time needed for maintaining the concentrations above IC50 after a single i.d. administration of KNI-174 is estimated to be 0.350 +/- 0.184 h.
|
Authors | A Kiriyama, T Mimoto, Y Kiso, K Takada |
Journal | Biopharmaceutics & drug disposition
(Biopharm Drug Dispos)
Vol. 14
Issue 3
Pg. 199-207
(Apr 1993)
ISSN: 0142-2782 [Print] England |
PMID | 8490108
(Publication Type: Journal Article)
|
Chemical References |
- HIV Protease Inhibitors
- Thiazoles
- Thiazolidines
- KNI 174
- Asparagine
|
Topics |
- Animals
- Asparagine
(administration & dosage, analogs & derivatives, pharmacokinetics)
- Biological Availability
- Chromatography, High Pressure Liquid
- Duodenum
- HIV Protease Inhibitors
(administration & dosage, pharmacokinetics)
- HIV-1
(drug effects, enzymology)
- Half-Life
- Injections, Intravenous
- Intubation, Gastrointestinal
- Male
- Rats
- Rats, Wistar
- Thiazoles
(administration & dosage, pharmacokinetics)
- Thiazolidines
|